Company: BGLC
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001477932-25-007976
Chunk: 7

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-07
Form: S-3
Chunk 7
---
, documents or information deemed to have been furnished and not filed in accordance with SEC rules):

| ● 
 ● | our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (filed with the SEC on April 15, 2025), as amended on Form 10-K/A filed with the SEC on April 29, 2025;                                                                                                                                                                                                                                                                                  
 our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2025 and June 30, 2025, filed with the SEC on May 15, 2025 and August 18, 2025, respectively;                                                                                                                                                                                                                                                                                          |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ● | our Current Reports on Form 8-K filed with the SEC on January 2, 2025, February 14, 2025, March 25, 2025, April 3, 2025, April 10, 2025, April 30, 2025 (excluding the information under Item 7.01 and Exhibit 99.1), and June 23, 2025;                                                                                                                                                                                                                            |
| ● | our Form 8-A12B, filed with the SEC on July 19, 2023; and                                                                                                                                                                                                                                                                                                                                                                                                           |
| ● | the description of the Company’s shares of Common Stock under the heading “Description of Capital Stock” contained in the Registration Statement on Form S-1 (File No. 333-269753), as originally filed on February 14, 2023 and as amended, and in the related prospectus filed pursuant to Rule 424(b) on July 21, 2023, each of which is incorporated herein by reference, including any amendment or report filed for the purpose of updating such description. |

We also incorporate by reference each of the documents that we file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, (i) after the date of this prospectus and prior to effectiveness of this registration statement on Form S-3 and (ii) on or after the date of this prospectus and prior to the termination of the offerings under this prospectus and any prospectus supplement. These documents include periodic reports, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8